Arrowhead Pharmaceuticals, Inc. (ARWR)
CIK 879407 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Arrowhead Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 20, 2026 | 4 | 0001250379-26-000002 |
| Aug 20, 2026 | 4 | 0001242615-26-000002 |
| Aug 18, 2026 | 144 | 0001628280-26-057774 |
| Aug 18, 2026 | 144 | 0001628280-26-057767 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0000902664-26-003461 |
| Aug 4, 2026 | 8-K | 0000879407-26-000058 |
| Aug 4, 2026 | 10-Q | 0000879407-26-000057 |
| Jul 31, 2026 | SCHEDULE 13G/A | 0002100121-26-000891 |
| Jul 27, 2026 | SCHEDULE 13G/A | 0002012383-26-002186 |
| Jun 17, 2026 | 4 | 0002141314-26-000004 |
| Jun 17, 2026 | 3 | 0002141314-26-000003 |
| Jun 16, 2026 | 8-K | 0000879407-26-000050 |
| May 19, 2026 | 144/A | 0001628280-26-036528 |
| May 19, 2026 | 144/A | 0001628280-26-036522 |
| May 19, 2026 | 144/A | 0001628280-26-036511 |
| May 14, 2026 | 4 | 0001767584-26-000002 |
| May 12, 2026 | 144 | 0001628280-26-034153 |
| May 7, 2026 | 8-K | 0000879407-26-000045 |
| May 7, 2026 | S-8 | 0001193125-26-212473 |
| May 7, 2026 | 10-Q | 0000879407-26-000047 |
| May 6, 2026 | SCHEDULE 13G | 0000315066-26-001120 |
| Apr 29, 2026 | SCHEDULE 13G | 0002100119-26-000162 |
| Apr 28, 2026 | SCHEDULE 13G | 0002100121-26-000087 |
| Apr 24, 2026 | 4 | 0000879407-26-000039 |
| Apr 24, 2026 | 4 | 0001830755-26-000007 |